Abstract

Aim: The A2UCOE sequence, positioned between the HNRPA2B1 and CBX3 gene promoters in the human genome, supports durable and consistent expression of integrated transgenes, even within compact heterochromatin domains such as centromeres. This project focuses on evaluating the dual-component hypothesis of A2UCOE function by analyzing alternative DNA elements that possess CpG-rich content and divergent promoter features.

Method: To investigate expression stability, lentiviral vectors carrying eGFP reporter constructs driven by novel UCOE candidates and various A2UCOE subregions were introduced into P19 and F9 mouse embryonal carcinoma cells. Expression was tracked over time, both before and after lineage-specific differentiation toward neuroectoderm and endoderm. To examine the proposed bipartite model of UCOE function, we employed two types of CpG-rich, bidirectionally transcribed elements: the endogenous SETD3–CCNK housekeeping gene pair, and a synthetically arranged divergent configuration composed of RPS11 and HNRPA2B1 promoters.

Results: Placing these regulatory elements in either orientation upstream of the SFFV-eGFP reporter gene—known for its susceptibility to transcriptional silencing—conferred a noticeable, though incomplete, resistance to silencing when compared to the full activity of the reference 1.5A2UCOE-SFFV-eGFP construct. This partial protective effect was consistently observed in both P19 and F9 cell lines, prior to and following their differentiation. In conclusion, we successfully identified a naturally occurring (SETD3–CCNK) and synthetically engineered (RPS11–HNRPA2B1) pair of divergent promoters that exhibited measurable but incomplete UCOE-like activity relative to the established HNRPA2B1–CBX3 core element.

Conclusion: This study demonstrates that natural and synthetic divergent promoter pairs confer significant, though partial, resistance to transgene silencing. This finding directly supports the A2UCOE's dual-component hypothesis, confirming that CpG-rich bidirectional architecture is key for sustaining stable expression through differentiation and in challenging genomic contexts.

Keywords: chromatin remodelling, gene silencing, lentiviral vector, neuroectodermal and endodermal differentiation, UCOE

Copyright and license

Copyright © 2025 The Author(s). This is an open-access article published by Bolu İzzet Baysal Training and Research Hospital under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Anakök ÖF, Arslan AO. Testing of novel CpG chromatin fragments as UCOE candidates for improved gene therapy vectors. Northwestern Med J. 2025;Early View:1-13. https://doi.org/10.54307/2025.NWMJ.167

References

  1. Antoniou MN, Skipper KA, Anakok O. Optimizing retroviral gene expression for effective therapies. Hum Gene Ther. 2013; 24(4): 363-74. https://doi.org/10.1089/hum.2013.062
  2. Griesenbach U, Alton EWFW. Moving forward: cystic fibrosis gene therapy. Hum Mol Genet. 2013; 22(R1): R52-8. https://doi.org/10.1093/hmg/ddt372
  3. Neville JJ, Orlando J, Mann K, McCloskey B, Antoniou MN. Ubiquitous Chromatin-opening Elements (UCOEs): applications in biomanufacturing and gene therapy. Biotechnol Adv. 2017; 35(5): 557-64. https://doi.org/10.1016/j.biotechadv.2017.05.004
  4. Sizer RE, White RJ. Use of ubiquitous chromatin opening elements (UCOE) as tools to maintain transgene expression in biotechnology. Comput Struct Biotechnol J. 2022; 21: 275-83. https://doi.org/10.1016/j.csbj.2022.11.059
  5. Fu Y, Han Z, Cheng W, Niu S, Wang T, Wang X. Improvement strategies for transient gene expression in mammalian cells. Appl Microbiol Biotechnol. 2024; 108(1): 480. https://doi.org/10.1007/s00253-024-13315-y
  6. Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996; 272(5259): 263-7. https://doi.org/10.1126/science.272.5259.263
  7. Bouard D, Alazard-Dany D, Cosset FL. Viral vectors: from virology to transgene expression. Br J Pharmacol. 2009; 157(2): 153-65. https://doi.org/10.1038/bjp.2008.349
  8. Gurumoorthy N, Nordin F, Tye GJ, Wan Kamarul Zaman WS, Ng MH. Non-integrating lentiviral vectors in clinical applications: a glance through. Biomedicines. 2022; 10(1): 107. https://doi.org/10.3390/biomedicines10010107
  9. Teich NM, Weiss RA, Martin GR, Lowy DR. Virus infection of murine teratocarcinoma stem cell lines. Cell. 1977; 12(4): 973-82. https://doi.org/10.1016/0092-8674(77)90162-3
  10. Speers WC, Gautsch JW, Dixon FJ. Silent infection of murine embryonal carcinoma cells by Moloney murine leukemia virus. Virology. 1980; 105(1): 241-4. https://doi.org/10.1016/0042-6822(80)90171-3
  11. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J. 1998; 17(17): 4905-8. https://doi.org/10.1093/emboj/17.17.4905
  12. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev. 2005; 15(5): 490-5. https://doi.org/10.1016/j.gde.2005.08.002
  13. Benton T, Chen T, McEntee M, et al. The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology. 2002; 38(1-3): 43-6. https://doi.org/10.1023/A
  14. Ellis J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther. 2005; 16(11): 1241-6. https://doi.org/10.1089/hum.2005.16.1241
  15. Zhang F, Thornhill SI, Howe SJ, et al. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood. 2007; 110(5): 1448-57. https://doi.org/10.1182/blood-2006-12-060814
  16. Zhang F, Frost AR, Blundell MP, Bales O, Antoniou MN, Thrasher AJ. A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. Mol Ther. 2010; 18(9): 1640-9. https://doi.org/10.1038/mt.2010.132
  17. Antoniou M, Harland L, Mustoe T, et al. Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics. 2003; 82(3): 269-79. https://doi.org/10.1016/s0888-7543(03)00107-1
  18. Williams S, Mustoe T, Mulcahy T, et al. CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol. 2005; 5: 17. https://doi.org/10.1186/1472-6750-5-17
  19. Lindahl Allen M, Antoniou M. Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE). Epigenetics. 2007; 2(4): 227-36. https://doi.org/10.4161/epi.2.4.5231
  20. Talbot GE, Waddington SN, Bales O, Tchen RC, Antoniou MN. Desmin-regulated lentiviral vectors for skeletal muscle gene transfer. Mol Ther. 2010; 18(3): 601-8. https://doi.org/10.1038/mt.2009.267
  21. Brendel C, Müller-Kuller U, Schultze-Strasser S, et al. Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter. Gene Ther. 2012; 19(10): 1018-29. https://doi.org/10.1038/gt.2011.167
  22. Cavazzana-Calvo M, Fischer A, Hacein-Bey-Abina S, Aiuti A. Gene therapy for primary immunodeficiencies: part 1. Curr Opin Immunol. 2012; 32(1): 44-53. https://doi.org/10.1016/j.coi.2012.08.008
  23. Aiuti A, Bacchetta R, Seger R, Villa A, Cavazzana-Calvo M. Gene therapy for primary immunodeficiencies: Part 2. Curr Opin Immunol. 2012; 24(5): 585-91. https://doi.org/10.1016/j.coi.2012.07.012
  24. Yoon JS, Lee MY, Lee JS, Park CS, Youn HJ, Lee JH. Bis is involved in glial differentiation of p19 cells induced by retinoic Acid. Korean J Physiol Pharmacol. 2009; 13(3): 251-6. https://doi.org/10.4196/kjpp.2009.13.3.251
  25. Pfaff N, Lachmann N, Ackermann M, et al. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells. 2013; 31(3): 488-99. https://doi.org/10.1002/stem.1316
  26. Skipper KA, Hollensen AK, Antoniou MN, Mikkelsen JG. Sustained transgene expression from sleeping beauty DNA transposons containing a core fragment of the HNRPA2B1-CBX3 ubiquitous chromatin opening element (UCOE). BMC Biotechnol. 2019; 19(1): 75. https://doi.org/10.1186/s12896-019-0570-2
  27. Knight S, Zhang F, Mueller-Kuller U, et al. Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing. J Virol. 2012; 86(17): 9088-95. https://doi.org/10.1128/JVI.00485-12
  28. Hasheminejad F, Amiri-Yekta A. Recombinant protein expression optimizing: a review of S/MAR, STAR, and UCOE, as a chromatin-modifying element. West Kazakhstan Medical Journal. 2024; 137-145. https://doi.org/10.18502/wkmj.v66i2.16456
  29. Seymour BJ, Singh S, Certo HM, et al. Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector. Mol Ther Methods Clin Dev. 2021; 20: 635-51. https://doi.org/10.1016/j.omtm.2021.01.007